← Back to Search

Behavioural Intervention

Family Physician Consultations for Rheumatoid Arthritis

N/A

Waitlist Available

Led By Cassandra Schulz

Research Sponsored by Western University, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants will be patients of the Waterloo Rheumatology Community Clinic, aged 18 to 80 years of age, with a diagnosis of rheumatoid arthritis

Be older than 18 years old

Must not have

Age less than 18 years or greater than 80 years

Significant cognitive impairment that impedes ability to engage in the study or unwilling to participate in the study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if adding a family doctor to a team of rheumatologists can help improve the overall health of people with rheumatoid arthritis. The family doctor will focus on vaccinations, heart

Who is the study for?

This trial is for people with rheumatoid arthritis, a condition where the immune system mistakenly attacks the body. Participants should be seeing a rheumatologist regularly and need help managing related health issues like infections, heart problems, and bone strength.

What is being tested?

The study tests if adding a family doctor to the patient's healthcare team improves management of comorbidities in rheumatic diseases. It involves special consultations focusing on vaccinations, heart health screenings, and bone density assessments.

What are the potential side effects?

Since this trial focuses on consultation rather than medication or invasive procedures, there are no direct side effects from interventions being studied. However, changes in routines or medications recommended after checkups could have their own side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18-80 years old with rheumatoid arthritis and a patient at the Waterloo Rheumatology Clinic.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am younger than 18 or older than 80.

Select...

I am able to understand and willing to participate in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Care Gap: Cardiovascular screening

Care Gap: Osteoporosis screening

Care Gap: Pneumococcal vaccination

Secondary study objectives

Care Gap: Comorbidity treatment with medication

Care Gap: vaccine-preventable diseases (herpes zoster, influenza and COVID-19)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Comprehensive Comorbidity ClinicExperimental Treatment1 Intervention

The following investigations and treatments will be offered as associated with a comprehensive comorbidity clinic appointment with the primary care rheumatology family physician: Blood pressure, heart rate, height and weight measurement. Blood work (standard lipid panel, fasting plasma glucose or glycated hemoglobin (A1C), eGFR, and Lipoprotein a, Bone densitometry (if applicable to the patient/participant). Vaccinations will be offered if applicable to the patient/participant according to Health Canada guidelines (Vaccination with Pneu-P-23, Pneu-C-13, herpes zoster and COVID-19 vaccine).

0 / 3Eligibility criteria met